Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Liver Pathology

Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation

Wonkyung Jung, Baek-hui Kim

Clin Mol Hepatol. 2015;21(2):183-186. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.183

View: 6616 Download: 62 Web of Science: 5 Crossref: 5

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma

Sang Jae Noh, Hyun Kyung Lee, Hee Chul Yu, Woo Sung Moon

Clin Mol Hepatol. 2012;18(4):416-419. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.416

View: 6114 Download: 57 Crossref: 2

5

Combined Hepatocellular-cholangiocarcinoma

Yoon Mi Jeen , So Young Jin

Clin Mol Hepatol. 2007;13(4):571-575. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.571

View: 3646 Download: 15

6

Combined Hepatocellular-cholangiocarcinoma

Joon Koo Han , Se Hyung Kim , Soo Jin Kim

Clin Mol Hepatol. 2007;13(1):112-115. Published online January 1, 1970

View: 2532 Download: 16

4

A Case of Combined Hepatocellular-Cholangiocarcinoma with Sarcomatous Transformation and Second Primary Colon Cancer

Jae Hi Kim, M.D., Yong Gu Lee, M.D., Jun Lee, M.D., Cheol Kweon Jung, M.D., Hyeong Tae Kim, M.D., Haeyoun Kang, M.D.*, Kwang Hyun Kho, M.D., Sung Pyo Hong, M.D., Seong Gyu Hwang, M.D., Pil Won Park, M.D. and Gyu Sung Rim, M.D.

Clin Mol Hepatol. 2004;10(2):142-147. Published online January 1, 1970

View: 2132 Download: 18

Combined Hepatocellular and Cholangiocarcinoma , Separate Type - A Case Report

Ho Sung Park, Jeong Min Lee*, Hee Chul Yu†, Woo Sung Moon

Clin Mol Hepatol. 2001;7(2):201-205. Published online January 1, 2000

View: 2296 Download: 14

3

Comparison of Endoscopic Variceal Ligation versus Combined Ligation and Sclerotherapy for Bleeding Esophageal Varices

Kyong Han Shin , June Sung Lee , Jung Hwan Yoon , Chul Joo Han , Hyo Suk Lee , Chung Yong Kim

Clin Mol Hepatol. 1998;4(2):143-150.

View: 2113 Download: 14

1 |

Viewed By 5346	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5294	MAFLD: How is it different from NAFLD?
Viewed By 5192	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3886	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3840	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search